| Literature DB >> 34654631 |
B O Botwe1, W K Antwi2, J A Adusei3, R N Mayeden4, T N Akudjedu5, S D Sule6.
Abstract
INTRODUCTION: Vaccination is a key global strategy to mitigate the clinical impact of the COVID-19 virus. As part of local efforts to manage the outbreak, the government of Ghana announced its intention to vaccinate its population starting with essential and high-risk workers including radiographers. However, there were reports of hesitance to receiving the vaccine among the radiography workforce. This study was undertaken prior to the intended vaccination exercise to assess the willingness and concerns of radiographers to undergo the COVID-19 vaccination and to suggest recommendations to improve the vaccine uptake.Entities:
Keywords: COVID-19; Ghana; Radiographer; Survey; Vaccine hesitancy
Mesh:
Substances:
Year: 2021 PMID: 34654631 PMCID: PMC8498685 DOI: 10.1016/j.radi.2021.09.015
Source DB: PubMed Journal: Radiography (Lond) ISSN: 1078-8174
Demographic characteristics of the respondents.
| Demographic parameters | Frequency |
|---|---|
| Male | 73 (67.6%) |
| Female | 35 (32.4%) |
| 20–29 | 55 (50.9%) |
| 30–39 | 35 (32.4%) |
| 40–49 | 16 (14.8% |
| 50–59 | 2 (1.9%) |
| ≥60 | 0 (0%) |
| <10 | 66 (61.1%) |
| 10–20 | 35 (32.4%) |
| >20 | 7 (6.5%) |
| Government sector | 97 (73.1%) |
| Private sector | 20 (18.5%) |
| Quasi-government | 9 (8.3%) |
| Certificate/diploma qualification | 5 (4.6%) |
| Bachelor's degree (BSc) | 81 (75.0%) |
| Postgraduate certificate/diploma | 4 (3.7%) |
| Master's degree | 15 (13.9%) |
| Doctor of Philosophy | 3 (2.8%) |
yrs = years
Figure 1Respondents self-described knowledge level about COVID-19 vaccines (Note: Moderate is average and Adequate is satisfactory).
Types of vaccines known by respondents.
| Types of vaccines | Frequency( | Percentage (%) |
|---|---|---|
| Oxford-Astra Zeneca | 64 | 59.3 |
| Pfizer-BioNTech | 71 | 65.7 |
| Moderna | 26 | 24.1 |
| Sputnik V | 29 | 26.9 |
| Novavax (NVX-CoV2373) | 16 | 14.8 |
| Sinopharm | 8 | 7.4 |
| Sinovac | 21 | 19.4 |
| Johnson and Johnson's Janssen | 2 | 1.9 |
| I do not know | 1 | 0.9 |
Reasons why respondents will accept the COVID-19 vaccine (n = 64).
| Reason | Frequency | |
|---|---|---|
| % | ||
| Vaccination will help curb the spread and reduce the number of cases and deaths. | 35 | 54.7 |
| It will help us to achieve heard immunity. | 9 | 14.1 |
| I trust the effectiveness, efficiency of the vaccine which comes with minimal side effects. | 2 | 3.1 |
| Taking of the vaccine is inevitable, it is the only main solution to the pandemic. | 8 | 12.5 |
| I have enough knowledge of it. | 2 | 3.1 |
| It has been scientifically tested and approved by the food and drugs authority (FDA) and WHO. | 4 | 6.3 |
| It is quite safe, and the benefits outweigh the risk. | 3 | 4.7 |
| I think it will work like other vaccines worked in the past. | 1 | 1.6 |
Reasons for not accepting COVID-19 vaccines (n = 44).
| Reason | Frequency | |
|---|---|---|
| % | ||
| Not convinced about its effectiveness and side effects. | 25 | 56.8 |
| Not interested. | 2 | 4.5 |
| No evidence on effects on my type of race and population (Ghanaians). | 4 | 9.1 |
| Due to adverse reactions to previous vaccines eg. H1N1 vaccine in 2012. | 1 | 2.3 |
| Lack of adequate information and education. | 3 | 6.8 |
| Lack of enough research evidence to back the potency of the vaccines. | 5 | 11.4 |
| Not sure if it affects fertility. | 2 | 4.5 |
| I have heard of some severe side effects. | 1 | 2.3 |
| I do not know whether people with underlying conditions can take it. | 1 | 2.3 |
Figure 2Key demographic characteristics of respondents who indicated their unwillingness and willingness to have a COVID-19 vaccine.
Figure 3Respondents' perception of about COVID-19 vaccination.